Junlai Wan
Impact in
- Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications
Papers in
- Rheumatology 10
- Osteoarthritis Treatment and Mechanisms 10
-
- Spine and Intervertebral Disc Pathology 2
- Co-authors
- Anmin Chen (8 shared papers)Zhiyi He (8 shared papers)Peng Cheng (7 shared papers)Jiaming Zhang (3 shared papers)Xiaoxia Hao (2 shared papers)Jiarui Cui (2 shared papers)Xiaopei Wu (2 shared papers)Renpeng Peng (1 shared paper)
In The Last Decade
Junlai Wan
17 papers receiving 350 citations
Junlai Wan's Hit Papers
Peers
Comparison fields: 5 of 49
- Rheumatology 125
- Molecular Medicine 48
- Pulmonary and Respiratory Medicine 48
- Biomaterials 17
- Rehabilitation 7
Countries citing papers authored by Junlai Wan
This map shows the geographic impact of Junlai Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlai Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlai Wan more than expected).
Fields of papers citing papers by Junlai Wan
This network shows the impact of papers produced by Junlai Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlai Wan. The network helps show where Junlai Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Junlai Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Injectable photocrosslinking spherical hydrogel-encapsulated targeting peptide-modified engineered exosomes for osteoarthritis therapy Hit paper breakdown → | 2023 | 97 |
| 2 | 2022 | 55 | |
| 3 | 2022 | 30 | |
| 4 | 2022 | 26 | |
| 5 | 2023 | 25 | |
| 6 | 2021 | 22 | |
| 7 | 2023 | 19 | |
| 8 | 2024 | 17 | |
| 9 | 2023 | 14 | |
| 10 | 2015 | 12 | |
| 11 | 2025 | 11 | |
| 12 | 2023 | 8 | |
| 13 | 2024 | 8 | |
| 14 | 2021 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 1 | |
| 18 | 2025 | 0 |
About Junlai Wan
Junlai Wan is a scholar working on Rheumatology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Molecular Medicine and Biomaterials, having authored 18 papers that have together received 358 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (10 papers), Spine and Intervertebral Disc Pathology (2 papers), Renal cell carcinoma treatment (2 papers), Hydrogels: synthesis, properties, applications (1 paper), MXene and MAX Phase Materials (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Orthopedic Surgery and Rehabilitation (1 paper) and Kidney Stones and Urolithiasis Treatments (1 paper). The work is most often cited by research in Rheumatology (125 citations), Molecular Medicine (48 citations), Pulmonary and Respiratory Medicine (48 citations), Biomaterials (17 citations) and Rehabilitation (7 citations). Junlai Wan has collaborated with scholars based in China, Sweden and Japan. Frequent co-authors include Anmin Chen, Zhiyi He, Peng Cheng, Jiaming Zhang, Xiaoxia Hao, Jiarui Cui, Xiaopei Wu, Renpeng Peng, Jiaqiao Zhang and Jin‐Zhou Xu. Their work appears in journals such as Journal of Nanobiotechnology, International Immunopharmacology, Journal of Controlled Release, Frontiers in Bioengineering and Biotechnology and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.